الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
11 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Dr. Salah Mabrouk Khallaf Abd Rabou 2025
12 Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients Dr. Amen Hamdy Zaki Ali 2025
13 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Samar Abotaleb Mahmou 2024
14 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Amen Hamdy Zaki Ali 2024
15 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Amany Mohammed Abdel Moatamed 2024
16 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Hanaan Ahmed Mohammed Ahmed 2024
17 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Dr. Salah Mabrouk Khallaf Abd Rabou 2024
18 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Dr. Shimaa Hassan Shabaan Hassan 2024
19 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Adel Gomaa Mohamed Gabr 2024
20 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Dr. Amen Hamdy Zaki Ali 2024